CANF
Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
CANF Stock Analysis: Buy, Sell, or Hold?
$1.42
-0.07 (-4.70%)
▼
5d:
-12.35%
30d:
-23.24%
90d:
-60.34%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$1.59 – $1.96
Position: OVERSOLD
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$8.00
+463.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.42 / $1.70
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CANF is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When CANF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CANF is currently trading at $1.42, which is considered oversold relative to its 30-day fair value range of $1.59 to $1.96.
Technical Outlook: Technically, CANF is in a strong downtrend. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CANF scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.00 (+463.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CANF is in a strong downtrend. The price is currently testing key support at $1.42. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: CANF scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.00 (+463.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.59 -
$1.96
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$1.59 -
$1.96
Current vs Trading Range
OVERSOLD
Support Level
$1.42
Resistance Level
$1.70
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 463.4% below Wall St target ($8.00)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.56
Wall Street Target
$8.00
(+463.4%)
Share CANF Analysis
Share this live CANF analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 13, 2026 5:28 PM ET
Data refreshes hourly during market hours. Next update: 6:28 PM
Data refreshes hourly during market hours. Next update: 6:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CANF showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 52 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 43 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CANF Research Pages
